Greek First Edition of the Libri Medicinales, Books 10 and 14, by Aetius of Amida (6. cent. A.D.) with a German Translation, a Medical-Historical Commentary and an Analysis of the Sources

该项目旨在为阿米达的埃蒂乌斯(6美分)编写的拜占庭早期汇编(L·伊阿特科伊，天秤座医学)第10和14册的关键第一版。公元后)。到目前为止，这些书从未用希腊语编辑过，因此构成了古希腊医学著作的最后一大编辑空白。这两本书的所有已知手稿都将用于这一第一版。该版本将附有德语翻译和语言学以及医学史评论。计划建立一种新的编辑方法，确保读者和研究人员最大限度地方便用户：将在单独的卷中出版一篇摘要，其中埃蒂乌斯的文本和埃蒂乌斯摘录的文本段落(以其原始措辞)将按句法印刷。这两个文本的不同之处将通过一个图形标记系统来突出。因此，读者将能够立即检查哪些段落被埃蒂乌斯浓缩、修改或改写。这样，埃蒂乌斯的摘录技术将被系统地可视化，从而随时可供语言学家或对思想史感兴趣的研究人员进行进一步分析。遵循扩展批评版的概念，仍未出版的最后一批早期拜占庭医学文献将被广泛的研究人员(古典主义者、医学史学家、药剂学家、科学、文化学家以及拜占庭主义者)获取。

The project aims at a critical first edition of books 10 and 14 of the early Byzantine compilation (lógoi iatrikoí, Libri medicinales) by Aetius of Amida (6th cent. A.D.). These books have never been edited in Greek so far and thus constitute the last big editorial gap of ancient Greek medical writing. All known manuscripts of these two books will be used for this first edition. The edition will be accompanied by a German translation and a philological as well as a medico-historical commentary. Thus the work will be made accessible for a larger circle of readers.It is planned to establish a new editorial method that will ensure a maximum of user-friendlyness for the reader and researchers: In a separate volume a concordance will be published in which both Aetius' text and the text passages excerpted by Aetius (in their original wording) will be printed synoptically. Divergences of these two textual versions will be highlighted by a system of graphic markings.The reader will therefore immediately be able to check which passages have been condensed, modified or reworded by Aetius. This way Aetius' excerpting technique will systematically be visualised and thus readily made available for further analysis, either by philologists or researchers interested in the history of ideas.Following this concept of an extended critical edition the very last early Byzantine medical texts still unpublished will be made accessible to a wide scope of researchers (classicists, historians of medicine, pharmacy, science, culture as well as Byzantinists).